Vanguard Group
GTBP icon

Vanguard Group’s GT Biopharma GTBP Stock Holding History

Vanguard Group’s Portfolio GTBP Stock Details GTBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,504
Closed -$6.25K – 4360
2025
Q3 		$6.25K Hold
10,504
– – ﹤0.01% 4342
2025
Q2 		$37.6K Hold
10,504
– – ﹤0.01% 4212
2025
Q1 		$23.5K Hold
10,504
– – ﹤0.01% 4234
2024
Q4 		$32K Hold
10,504
– – ﹤0.01% 4237
2024
Q3 		$24.1K Hold
10,504
– – ﹤0.01% 4291
2024
Q2 		$29.7K Sell
10,504
-10,008
-49% -$35.8K ﹤0.01% 4335
2024
Q1 		$90.9K Sell
20,512
-15,754
-43% -$83.2K ﹤0.01% 4253
2023
Q4 		$277K Buy
36,266
+25
+0.1% +$183 ﹤0.01% 4172
2023
Q3 		$262K Sell
36,241
-404
-1% -$3.34K ﹤0.01% 4202
2023
Q2 		$343K Sell
36,645
-935
-2% -$9.7K ﹤0.01% 4213
2023
Q1 		$620K Hold
37,580
– – ﹤0.01% 4060
2022
Q4 		$999K Buy
37,580
+15
+0% +$749 ﹤0.01% 3916
2022
Q3 		$1.98M Buy
37,565
+4
+0% +$306 ﹤0.01% 3745
2022
Q2 		$3.37M Buy
37,561
+4,630
+14% +$351K ﹤0.01% 3570
2022
Q1 		$2.85M Sell
32,931
-7,281
-18% -$642K ﹤0.01% 3800
2021
Q4 		$3.68M Buy
40,212
+8,101
+25% +$1.21M ﹤0.01% 3780
2021
Q3 		$6.49M Sell
32,111
-631
-2% -$190K ﹤0.01% 3500
2021
Q2 		$15.2M Buy
32,742
+23,820
+267% +$9.9M ﹤0.01% 2984
2021
Q1 		$1.83M Buy
+8,922
New +$1.56M ﹤0.01% 3880

Other funds holding GTBP

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $12.5B AUM 18.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CMP
Coston McIsaac & Partners Bar Harbor, Maine $443M AUM 6.68% 1-Year Est. Return
CJ
Caitlin John Brighton, Michigan $167M AUM 23.74% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Vanguard Group's GTBP Position: Q4 2025 in Review

Vanguard Group sold out of GT Biopharma (GTBP) in Q4 2025, closing a stake of 10,504 shares — an estimated $6.25K sold.

Vanguard Group first reported a position in GTBP in Q1 2021 and held it in 19 quarters. The position peaked at $15.2M in Q2 2021. 38 funds tracked by Wall St. Rank hold GTBP as of Q4 2025.

  • Vanguard Group reported no remaining GT Biopharma position as of Q4 2025 after selling out during the quarter.
  • Vanguard Group sold 10,504 GT Biopharma shares in Q4 2025, an estimated $6.25K.
  • Vanguard Group first reported a position in GT Biopharma in Q1 2021 and held it in 19 quarters.
  • Vanguard Group's GT Biopharma position peaked at $15.2M in Q2 2021.
  • 38 funds tracked by Wall St. Rank held GT Biopharma as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.